Dr. Marty Makary, nominee to be commissioner of the U.S. Food and Drug Administration (FDA), appears before the Senate Health, Education, Labor and Pensions Committee for his confirmation hearing on Thursday, March 6, 2025, in Washington, D.C.

Jim Jones, director of the Food and Drug Administration’s food division, slammed the “indiscriminate firing” of dozens of his employees and recent rhetoric from Health and Human Services Secretary Robert F. Kennedy in his resignation letter, which The Washington Post has reproduced below.

THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Marty Makary, MD, MPH, President Trump's nominee for FDA commissioner, seems likely to be a lock for the position if Thursday's nomination hearing before the Senate Health, Education, Labor & Pensions (HELP) Committee is any indication.

FDA staffers tell CR how the suspension of their discretionary spending is threatening the safety of the American food supply, putting consumers at risk.

A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss drug Zepbound in the U.S. The decision was filed late on Wednesday in response to an October lawsuit from a compounding industry group against the U.